The patients who wish to take part in the clinical research are told about the aim of the project, about what will happen in the course of its realization, about risks and possible benefit from participation, provide information on the studied medicine.
Participation in the clinical study is voluntary during the whole period.
Advantages for you:
• Access to modern treatment methods developed with participation of the leading Russian and foreign drug manufacturers;
• Thorough free medical examination, follow-up and consultations;
BESSALAR Clinic employs highly-qualified personnel that has many years of experience in treatment and conducting clinical research.
Th clinic’s priority is safety, well-being and observation of patients’ rights.
Conditions of the stay of patients:
• Round-the-clock medical observation and round-the-clock security post
• Comfortable wards
• Balanced nutrition
• WC with shower
• Rest area
• TV set
You can register for participation in the study by phone or by filling…
What are clinical research?
A clinical study allows to determine the efficiency of the drug, its safety, compatibility with other drugs, and dosage.
It is only after conducting clinical research that the drug may be registered and applied to treat patients.
Discovery of efficient methods of treatment of many severe diseases became possible thanks to patients’ aid.
What are the phases of clinical research?
Clinical research pass different phases, each of which reveals the data about the drug and its influence on the human body required in the study.
Phase 1 of the clinical study involves drug testing with participation of a small group (usually from 20 to 100) of healthy volunteers or patients. The toxicity, adverse effects and suitable dosage of the drug are determined.
Phase 2 of the study involves testing the drug on a large group of patients (usually from 100 to 500 persons) to determine the scheme of drug administration, its dosage and efficiency against certain diseases. Within this phase, the drug is compared with placebo or other drug which is used as a standard for disease treatment.
In Phase 3, the research drug is applied to a large group of patients up to three and more thousand. The research are aimed at confirmation of preliminary results of efficiency, tolerance and safety of the drug.
After the registration stage, the drug developer may conduct Phase 4 of the study. This Phase is carried out to collect additional information on drug application safety, study of its interaction with other drugs and therapy follow-up.
What is informed consent?
The patient is informed about all aspects of the clinical study, its methods, aims and procedures to be taken, duration of the study, use and possible risks.
After careful study of this information, the patient gives consent to participation in the study, signs a special document, a Form of Informed Consent.
Who can participate in the clinical study?
Each particular study requires patients that comply with certain parameters (inclusion/exclusion criteria): age, state of health, history of disease, etc.
What is the procedure of the clinical study?
After a detailed discussion of the clinical study and signing the form of informed consent, the patient undergoes a medical examination, after which the study participant receives the necessary instructions and recommendations. Participation in the study involves strict compliance with the protocol whose conditions will be presented to the patient by the studying physician.
After a detailed discussion of the clinical study and signing the form of informed consent, the volunteer undergoes a medical examination, after which the study participant receives the necessary instructions and recommendations. Participation in the study involves strict compliance with the protocol whose conditions will be presented to the volunteer by the studying physician.
Request for participation